Skip to main content

Part of the book series: NATO ASI Series ((NSSA,volume 270))

  • 39 Accesses

Abstract

Insulin-dependent diabetes mellitus (IDDM) is a clinical diabetes of severe insulin deficiency, resulting from a slowly progressing autoimmune destruction process of pancreatic beta cell. Noninsulin-dependent diabetes mellitus (NIDDM) is a less severe form of diabetes of unknown etiology, although insulin resistance is suspected as the prime abnormality. This distinction is sometimes difficult as there is no clear transition point to apply.1 Certain HLA class II molecules, particularly DR3 or DR4, have been known to be associated with IDDM susceptibility.2 With the recent advances of molecular biology, the presence of DNA sequences coding for non-aspartic acid in the 57th position of the DQ beta chain and arginine in the 52nd position of the DQ alpha chain are known to be highly associated with IDDM in Caucasians.3,4 The associations of HLA alleles with IDDM, but not with NIDDM, was taken as an evidence that IDDM and NIDDM are two distinctively different diseases. Recently, however, several investigators suggest that HLA might also play a role in NIDDM.5–8

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. WHO Expert Committee on Diabetes Mellitus, Second Report, Technical Report Series 646, World Health Organization, Geneva (1980).

    Google Scholar 

  2. J.L. Tiwari, P.I. Terasaki, Endocrinology, in: “HLA and Disease Associations,” J.L. Tiwari, P.I. Terasaki, eds., Springer-Verlag, New York, Berlin, Heidelberg, Tokyo (1985).

    Chapter  Google Scholar 

  3. J.A. Todd, J.I. Bell, H.O. McDevitt, HLA-DQ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus, Nature 329:599 (1987).

    Article  PubMed  CAS  Google Scholar 

  4. I. Khalil, L. d’Auriol, M. Gobet, et al., A combination of HLA DQ-Asp57-negative and HLA-DQ Arg52 confers susceptibility to insulin-dependent diabetes mellitus, J Clin Invest. 85:1315 (1990).

    Article  PubMed  CAS  Google Scholar 

  5. L. Groop, A. Miettinen, P-H. Groop, et al., Organ-specific autoimmunity and HLA-DR antigens as markers for ß-cell destruction in patients with Type II diabetes. Diabetes 37:99 (1988).

    Article  PubMed  CAS  Google Scholar 

  6. L. Groop, P-H Groop, S. Koskimies, Relationship between ß-cell function and HLA antigens in patients with Type II (non-insulin-dependent) diabetes, Diabetologia 29:757 (1986).

    Article  PubMed  CAS  Google Scholar 

  7. E. Tuomilehto-Wolf, J. Tuomilehto, A. Nissinen, et al., The search is over: The major genes for NIDDM were also found in the HLA region, Diabetes 41:91A (suppl. 1) (1992).

    Google Scholar 

  8. T. Ida, H. Kuzuya, M. Hattori, et al., Heterogeneity of non-insulin-dependent diabetes mellitus in HLA types and clinical features: Comparison with insulin-dependent diabetes mellitus, Endocrinol Japon 38:9 (1991).

    Article  CAS  Google Scholar 

  9. P.I. Terasaki, D. Bernoco, M.S. Park, et al., Microdroplet testing for HLA-A.-B,-C and-D antigens, Am J Clin Pathol. 69:103 (1978).

    PubMed  CAS  Google Scholar 

  10. G.F. Bottazo, A. Florin-Christensen, D. Doniach, Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies, Lancet ii:1279 (1974).

    Article  Google Scholar 

  11. G.S. Eisenbarth, M.A. Morris, R.M. Scearce, Cytotoxic antibodies to cloned rat insulinoma cells in serum of patients with diabetes mellitus. J Clin Invest. 67:403 (1981).

    Article  PubMed  CAS  Google Scholar 

  12. J.A. Todd, Genetic control of autoimmunity, Immunology Today 11:122 (1990).

    Article  PubMed  CAS  Google Scholar 

  13. A.E. Pontiroli, A. Calderara, F. Capra, et al., HLA phenotype and secondary failure to oral hypoglycaemic agents, (letter), Diabetologia 30:824 (1987).

    Article  PubMed  CAS  Google Scholar 

  14. P.A. Morel, J.S. Dorman, J.A. Todd, et al., Aspartic acid at position 57 of HLA DQ-ß chain protects against Type I diabetes: A family study, Proc Natl Acad Sci. USA 85:8111 (1988).

    Article  PubMed  CAS  Google Scholar 

  15. K. Yamagata, T. Hanafusa, H. Nakajima, et al., HLA Al*l contributes to resistance and A 1*3 confers susceptibility to Type I (insulin-dependent) diabetes mellitus in Japanese subjects, Diabetologia 34:133 (1991).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lee, H.K. et al. (1994). Immunogenetic Aspects of Adult Onset IDDM in Korea. In: Dorman, J.S. (eds) Standardization of Epidemiologic Studies of Host Susceptibility. NATO ASI Series, vol 270. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1213-8_26

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1213-8_26

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1215-2

  • Online ISBN: 978-1-4899-1213-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics